Researchers introduced and characterized a novel platform based on monoclonal antibodies (mAbs).
Plus, news about Agile Therapeutics, Insud, Werewolf Therapeutics and Allakos: Taysha Gene Therapies sells $75M in shares: The biotech is Sign up to read this
VANCOUVER, BC, April 15, 2024 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company“) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral health